Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10603753 | 0.89 | ALOX12 (0.47) | KDM4EPOLBALOX12LMNASMN1; SMN2 | |
| SCHEMBL3859731 | 0.83 | KDM4E (0.35) | KDM4EPOLBALOX12LMNASMN1; SMN2 | |
| SCHEMBL27616352 | 0.76 | ALOX12 (0.42) | KDM4EPOLBALOX12LMNASMN1; SMN2 | |
| SCHEMBL17865898 | 0.74 | ALOX12 (0.43) | KDM4EPOLBALOX12LMNASMN1; SMN2 | |
| SCHEMBL1726687 | 0.72 | KMT2A (0.36) | HPGD | |
| SCHEMBL28363104 | 0.72 | SMN1; SMN2 (0.36) | LMNASMN1; SMN2 | |
| SCHEMBL29579731 | 0.70 | MEN1 (0.36) | POLBLMNASMN1; SMN2MAPK1HPGD | |
| SCHEMBL4882564 | 0.70 | MGLL (0.53) | KDM4EPOLBALOX12LMNASMN1; SMN2 | |
| SCHEMBL20147087 | 0.70 | MGLL (0.33) | HPGD | |
| SCHEMBL16290005 | 0.70 | ALOX12 (0.53) | KDM4EPOLBALOX12LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118178636-A | Immunogenic compositions and uses thereof | 镁迪生医股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| JP-7099976-A | — | — | None | — | — | JP | disclosed |
| CN-110582293-B | Synthetic factor compositions and methods of use | 小利兰·斯坦福大学托管委员会 | 2025-04-04 | — | — | CN | disclosed |
| CN-119303072-A | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | 辉瑞公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-110787290-B | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | 辉瑞公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-110945086-B | Coating for removing aldehydes and preparation method thereof | 陶氏环球技术有限责任公司 | 2022-09-16 | — | — | CN | disclosed |
| EP-3083659-B1 | VIRAL PEPTIDES | EQUIGERMINAL SA (PT) | 2021-07-28 | — | — | EP | disclosed |
| US-20200368365-A1 | COMPOUNDS AND COMPOSITIONS FOR TARGETING BRAIN INJURIES AND METHODS OF USE THEREOF | Sanford Burnham Prebys Medical Discovery Institute | 2020-11-26 | — | — | US | disclosed |
| US-20160367659-A1 | VIRAL PEPTIDES | EQUIGERMINAL SA (PT) | 2016-12-22 | — | — | US | disclosed |
| EP-3083659-A1 | VIRAL PEPTIDES | Equigerminal SA (PT) | 2016-10-26 | — | — | EP | disclosed |
| EP-0233619-B1 | HIGH MOLECULAR COMPOUNDS HAVING AMINO GROUPS, AND THEIR UTILIZATION | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1992-12-30 | — | — | EP | disclosed |
| EP-0507948-A1 | MONOCLONAL ANTIBODY, HYBRIDOMAS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-10-14 | — | — | EP | disclosed |
| WO-1991009875-A1 | MONOCLONAL ANTIBODY, HYBRIDOMAS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-07-11 | — | — | WO | disclosed |
| EP-0420081-A1 | Monoclonal antibody against an acidic FGF protein, its production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-04-03 | — | — | EP | disclosed |
| EP-0418590-A1 | Antibodies, production thereof and use | Takeda Chemical Industries, Ltd. (JP) | 1991-03-27 | — | — | EP | disclosed |
| EP-0351244-A2 | Antibodies and methods for immunochemical assay using them | Takeda Chemical Industries, Ltd. (JP) | 1990-01-17 | — | — | EP | disclosed |
| US-4855353-A | High molecular compounds having amino groups, and their utilization | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1989-08-08 | — | — | US | disclosed |
| US-4693968-A | IMMUNOLOGY | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1987-09-15 | — | — | US | disclosed |
| EP-0233619-A1 | High molecular compounds having amino groups, and their utilization | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1987-08-26 | — | — | EP | disclosed |
| JP-H00799976-A | — | — | 0001-01-01 | — | — | JP | disclosed |